UCB SA (EBR:UCB)
Belgium · Delayed Price · Currency is EUR 241.80
-0.40 (-0.17%)
Dec 10, 2025, 10:04 AM CET
UCB SA Market Cap
UCB SA has a market cap or net worth of €46.02 billion as of December 9, 2025. Its market cap has increased by 30.86% in one year.
Market Cap
46.02B
Enterprise Value
47.28B
Revenue
6.85B
Ranking
n/a
PE Ratio
35.27
Stock Price
€241.80
Market Cap Chart
Since April 5, 1995, UCB SA's market cap has increased from 890.67M to 46.02B, an increase of 5,066.59%. That is a compound annual growth rate of 13.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 46.02B | 26.20% |
| Dec 31, 2024 | 36.46B | 143.60% |
| Dec 29, 2023 | 14.97B | 7.12% |
| Dec 30, 2022 | 13.97B | -26.25% |
| Dec 31, 2021 | 18.95B | 18.70% |
| Dec 31, 2020 | 15.96B | 19.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 47.03B |
| Financière de Tubize | 9.66B |
| Fagron NV | 1.49B |
| Ion Beam Applications | 326.03M |
| Onward Medical | 183.21M |
| Nyxoah | 182.43M |
| Hyloris Pharmaceuticals | 168.00M |
| Sequana Medical NV | 39.26M |